| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-08 |
| mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
6e-07 |
| mRNA |
Irinotecan |
CCLE |
pan-cancer |
AAC |
0.26 |
1e-06 |
| mRNA |
BRD-K02251932 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-06 |
| mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
0.2 |
3e-06 |
| mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-06 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-06 |
| mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-06 |
| mRNA |
manumycin A |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-05 |
| mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |